Stratos Wealth Partners LTD. Purchases 62,795 Shares of Tilray Inc (NASDAQ:TLRY)

Stratos Wealth Partners LTD. increased its position in shares of Tilray Inc (NASDAQ:TLRY) by 61.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 165,558 shares of the company’s stock after purchasing an additional 62,795 shares during the period. Stratos Wealth Partners LTD.’s holdings in Tilray were worth $381,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Mercer Global Advisors Inc. ADV boosted its stake in Tilray by 10.0% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 28,072 shares of the company’s stock valued at $77,000 after buying an additional 2,550 shares in the last quarter. Rhumbline Advisers boosted its stake in Tilray by 20.4% in the 2nd quarter. Rhumbline Advisers now owns 15,464 shares of the company’s stock valued at $48,000 after buying an additional 2,623 shares in the last quarter. CreativeOne Wealth LLC boosted its stake in Tilray by 8.0% in the 3rd quarter. CreativeOne Wealth LLC now owns 40,591 shares of the company’s stock valued at $112,000 after buying an additional 2,994 shares in the last quarter. State of Wyoming boosted its stake in Tilray by 17.0% in the 4th quarter. State of Wyoming now owns 24,561 shares of the company’s stock valued at $66,000 after buying an additional 3,564 shares in the last quarter. Finally, Mariner LLC boosted its stake in Tilray by 11.1% in the 4th quarter. Mariner LLC now owns 49,469 shares of the company’s stock valued at $133,000 after buying an additional 4,945 shares in the last quarter. 9.35% of the stock is currently owned by institutional investors.

Tilray Trading Down 4.2 %

Tilray stock opened at $1.82 on Monday. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.92 and a quick ratio of 1.18. The business’s fifty day moving average is $1.97 and its two-hundred day moving average is $1.97. Tilray Inc has a 52 week low of $1.50 and a 52 week high of $3.40.

Analyst Upgrades and Downgrades

TLRY has been the topic of several recent analyst reports. Canaccord Genuity Group decreased their price target on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Alliance Global Partners boosted their price target on Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a research note on Friday, April 5th. Finally, CIBC reduced their price objective on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 10th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.